ABBOTT LABORATORIES — Director's Dealing 2007

Feb 6, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2006-12-19

Reporting Person: NEMMERS JOSEPH M (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-12-19	Common Shares without par value	G	1424	—	Disposed	82532	Direct
2007-02-02	Common Shares without par value	M	3170	$51.2943	Acquired	85702	Direct
2007-02-02	Common Shares without par value	M	2678	$43.00	Acquired	88380	Direct
2007-02-02	Common Shares without par value	S	5848	$52.608	Disposed	82532	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-02-02	Option (right to buy)	$51.2943	M	3170	Disposed	2007-02-13	common shares (3170)	Direct
2007-02-02	Option (right to buy)	$43.00	M	2678	Disposed	2007-02-13	common shares (2678)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares without par value	11116	Indirect
Common Shares without par value	355	Indirect
Common Shares without par value	298	Indirect
Common Shares without par value	291	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 2, 2007.

F2: Reporting person disclaims beneficial ownership of all securities held by his sons.

F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.